PHP
PEPG icon

Parkman Healthcare Partners’s PepGen PEPG Stock Holding History

Parkman Healthcare Partners’s Portfolio PEPG Stock Details PEPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,000
Closed -$908K – 91
2022
Q3 		$908K Buy
+100,000
New +$983K 0.26% 73

Other funds holding PEPG

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkman Healthcare Partners's PEPG Position: Q4 2022 in Review

Parkman Healthcare Partners sold out of PepGen (PEPG) in Q4 2022, closing a stake of 100,000 shares — an estimated $908K sold.

Parkman Healthcare Partners first reported a position in PEPG in Q3 2022 and held it in 1 quarter. The position peaked at $908K in Q3 2022. 46 funds tracked by Wall St. Rank hold PEPG as of Q4 2022.

  • Parkman Healthcare Partners reported no remaining PepGen position as of Q4 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 100,000 PepGen shares in Q4 2022, an estimated $908K.
  • Parkman Healthcare Partners first reported a position in PepGen in Q3 2022 and held it in 1 quarter.
  • Parkman Healthcare Partners's PepGen position peaked at $908K in Q3 2022.
  • 46 funds tracked by Wall St. Rank held PepGen as of Q4 2022.

Based on Parkman Healthcare Partners's 13F filing for Q4 2022, filed 13 Feb 2023.